Stereospecific activation of cardiac ATP-sensitive K+ channels by epoxyeicosatrienoic acids: A structural determinant study

Tong D Lu, Mike Vanrollins, Hon Chi Lee

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

The heart is richly endowed with KATP channels, which function as biological sensors, regulating membrane potentials and electrical excitability in response to metabolic alterations. We recently reported that the cytochrome P450 metabolites of arachidonic acid, epoxyeicosatrienoic acids (EETs), potently activate cardiac KATP channels by reducing channel sensitivity to ATP. In the present study, we further demonstrate that 11(S),12(R)-EET activated the cardiac KATP channels with an EC50 of 39.5 nM, whereas 11(R),12(S)-EET was totally inactive. In addition, 11 (S),12(R)-EET but not 11(R),12(S)-EET hyperpolarized the resting membrane potentials and shortened the duration of cardiomyocyte action potentials. By studying homologs and analogs of 11,12-EET, we also found that all four EET regioisomers are equipotent activators of the KATP channels, reducing the ATP sensitivity by more than 10-fold; however, neither altered chain length, double bond number, epoxide position, nor methylation of the carboxyl group affected channel inhibitions by ATP. All the fatty epoxides studied are potent KATP channel activators, but the ω-3 homolog was particularly potent, reducing ATP sensitivity 27-fold. Together, the results indicate that the presence of an epoxide group in a particular three-dimensional configuration is a critical determinant for KATP channel activation, and its effect is augmented by a double bond at ω-3 position. The results also suggest that fatty epoxides are important modulators of cardiac electrical excitability.

Original languageEnglish (US)
Pages (from-to)1076-1083
Number of pages8
JournalMolecular Pharmacology
Volume62
Issue number5
DOIs
StatePublished - Nov 1 2002

Fingerprint

KATP Channels
Adenosine Triphosphate
Epoxy Compounds
Acids
Membrane Potentials
Cardiac Myocytes
Arachidonic Acid
Cytochrome P-450 Enzyme System
Methylation
Action Potentials
11,12-epoxy-5,8,14-eicosatrienoic acid

ASJC Scopus subject areas

  • Pharmacology

Cite this

Stereospecific activation of cardiac ATP-sensitive K+ channels by epoxyeicosatrienoic acids : A structural determinant study. / Lu, Tong D; Vanrollins, Mike; Lee, Hon Chi.

In: Molecular Pharmacology, Vol. 62, No. 5, 01.11.2002, p. 1076-1083.

Research output: Contribution to journalArticle

@article{e919be2a5d4c433080ad55a5b3358959,
title = "Stereospecific activation of cardiac ATP-sensitive K+ channels by epoxyeicosatrienoic acids: A structural determinant study",
abstract = "The heart is richly endowed with KATP channels, which function as biological sensors, regulating membrane potentials and electrical excitability in response to metabolic alterations. We recently reported that the cytochrome P450 metabolites of arachidonic acid, epoxyeicosatrienoic acids (EETs), potently activate cardiac KATP channels by reducing channel sensitivity to ATP. In the present study, we further demonstrate that 11(S),12(R)-EET activated the cardiac KATP channels with an EC50 of 39.5 nM, whereas 11(R),12(S)-EET was totally inactive. In addition, 11 (S),12(R)-EET but not 11(R),12(S)-EET hyperpolarized the resting membrane potentials and shortened the duration of cardiomyocyte action potentials. By studying homologs and analogs of 11,12-EET, we also found that all four EET regioisomers are equipotent activators of the KATP channels, reducing the ATP sensitivity by more than 10-fold; however, neither altered chain length, double bond number, epoxide position, nor methylation of the carboxyl group affected channel inhibitions by ATP. All the fatty epoxides studied are potent KATP channel activators, but the ω-3 homolog was particularly potent, reducing ATP sensitivity 27-fold. Together, the results indicate that the presence of an epoxide group in a particular three-dimensional configuration is a critical determinant for KATP channel activation, and its effect is augmented by a double bond at ω-3 position. The results also suggest that fatty epoxides are important modulators of cardiac electrical excitability.",
author = "Lu, {Tong D} and Mike Vanrollins and Lee, {Hon Chi}",
year = "2002",
month = "11",
day = "1",
doi = "10.1124/mol.62.5.1076",
language = "English (US)",
volume = "62",
pages = "1076--1083",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "5",

}

TY - JOUR

T1 - Stereospecific activation of cardiac ATP-sensitive K+ channels by epoxyeicosatrienoic acids

T2 - A structural determinant study

AU - Lu, Tong D

AU - Vanrollins, Mike

AU - Lee, Hon Chi

PY - 2002/11/1

Y1 - 2002/11/1

N2 - The heart is richly endowed with KATP channels, which function as biological sensors, regulating membrane potentials and electrical excitability in response to metabolic alterations. We recently reported that the cytochrome P450 metabolites of arachidonic acid, epoxyeicosatrienoic acids (EETs), potently activate cardiac KATP channels by reducing channel sensitivity to ATP. In the present study, we further demonstrate that 11(S),12(R)-EET activated the cardiac KATP channels with an EC50 of 39.5 nM, whereas 11(R),12(S)-EET was totally inactive. In addition, 11 (S),12(R)-EET but not 11(R),12(S)-EET hyperpolarized the resting membrane potentials and shortened the duration of cardiomyocyte action potentials. By studying homologs and analogs of 11,12-EET, we also found that all four EET regioisomers are equipotent activators of the KATP channels, reducing the ATP sensitivity by more than 10-fold; however, neither altered chain length, double bond number, epoxide position, nor methylation of the carboxyl group affected channel inhibitions by ATP. All the fatty epoxides studied are potent KATP channel activators, but the ω-3 homolog was particularly potent, reducing ATP sensitivity 27-fold. Together, the results indicate that the presence of an epoxide group in a particular three-dimensional configuration is a critical determinant for KATP channel activation, and its effect is augmented by a double bond at ω-3 position. The results also suggest that fatty epoxides are important modulators of cardiac electrical excitability.

AB - The heart is richly endowed with KATP channels, which function as biological sensors, regulating membrane potentials and electrical excitability in response to metabolic alterations. We recently reported that the cytochrome P450 metabolites of arachidonic acid, epoxyeicosatrienoic acids (EETs), potently activate cardiac KATP channels by reducing channel sensitivity to ATP. In the present study, we further demonstrate that 11(S),12(R)-EET activated the cardiac KATP channels with an EC50 of 39.5 nM, whereas 11(R),12(S)-EET was totally inactive. In addition, 11 (S),12(R)-EET but not 11(R),12(S)-EET hyperpolarized the resting membrane potentials and shortened the duration of cardiomyocyte action potentials. By studying homologs and analogs of 11,12-EET, we also found that all four EET regioisomers are equipotent activators of the KATP channels, reducing the ATP sensitivity by more than 10-fold; however, neither altered chain length, double bond number, epoxide position, nor methylation of the carboxyl group affected channel inhibitions by ATP. All the fatty epoxides studied are potent KATP channel activators, but the ω-3 homolog was particularly potent, reducing ATP sensitivity 27-fold. Together, the results indicate that the presence of an epoxide group in a particular three-dimensional configuration is a critical determinant for KATP channel activation, and its effect is augmented by a double bond at ω-3 position. The results also suggest that fatty epoxides are important modulators of cardiac electrical excitability.

UR - http://www.scopus.com/inward/record.url?scp=0036840527&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036840527&partnerID=8YFLogxK

U2 - 10.1124/mol.62.5.1076

DO - 10.1124/mol.62.5.1076

M3 - Article

C2 - 12391270

AN - SCOPUS:0036840527

VL - 62

SP - 1076

EP - 1083

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 5

ER -